HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Nishiwaki Selected Research

Docetaxel (Taxotere)

9/2009Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.
5/2009Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).
1/2004A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.
8/2001A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer.
3/2001Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Nishiwaki Research Topics

Disease

10Neoplasms (Cancer)
09/2009 - 06/2000
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2009 - 03/2001
9Lung Neoplasms (Lung Cancer)
09/2009 - 06/2000
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2008 - 03/2000
5Adenocarcinoma
12/2001 - 03/2000
2Thymoma (Thymic Carcinoma)
06/2010 - 11/2009
2Neutropenia
06/2010 - 08/2001
2Fibrosis (Cirrhosis)
04/2006 - 03/2000
2Cholecystolithiasis
11/2005 - 10/2001
2Nausea
05/2004 - 07/2000
2Vomiting
05/2004 - 07/2000
2Adenocarcinoma of Lung
11/2001 - 01/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2001 - 03/2000
2Leukopenia
08/2001 - 03/2001
1Disease Progression
05/2009
1Pericardial Effusion
02/2009
1Pancreaticobiliary Maljunction
11/2005
1Cholecystitis
11/2005
1Polyps
11/2005
1Choledocholithiasis
11/2005
1Sleepiness
05/2004
1Motion Sickness (Airsickness)
05/2004
1Cardiotoxicity
03/2003
1Depressive Disorder (Melancholia)
11/2001
1Neoplasm Metastasis (Metastasis)
11/2001
1Tuberous Sclerosis (Bourneville's Disease)
11/2001
1Poisoning
11/2001
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2001
1Metaplasia
10/2001
1Radiation Pneumonitis
10/2001
1Infections
03/2001
1Pneumonia (Pneumonitis)
01/2001
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2001
1Papillary Adenocarcinoma
01/2001
1Hyperplasia
11/2000
1Hypotension (Low Blood Pressure)
11/2000
1Carcinogenesis
11/2000
1Carcinoma (Carcinomatosis)
11/2000
1Lymphoma (Lymphomas)
08/2000
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2000
1Amyloid Plaque
08/2000

Drug/Important Bio-Agent (IBA)

14Cisplatin (Platino)FDA LinkGeneric
06/2010 - 01/2001
6Etoposide (VP 16)FDA LinkGeneric
06/2010 - 11/2000
6Irinotecan (Camptosar)FDA LinkGeneric
02/2008 - 11/2000
5Docetaxel (Taxotere)FDA Link
09/2009 - 03/2001
4Carcinoembryonic AntigenIBA
08/2001 - 03/2000
2GemcitabineFDA Link
05/2009 - 02/2007
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2008 - 08/2001
2Biological ProductsIBA
04/2006 - 09/2000
2Proteins (Proteins, Gene)FDA Link
11/2005 - 10/2001
2Paclitaxel (Taxol)FDA LinkGeneric
12/2001 - 03/2001
1Vincristine (Oncovin)FDA LinkGeneric
06/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2010
1Gefitinib (Iressa)FDA Link
09/2009
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2009
1Carboplatin (JM8)FDA LinkGeneric
02/2007
1PlatinumIBA
02/2007
1Vinorelbine (Navelbine)FDA LinkGeneric
02/2007
1phytobacteriomycin (PBM)IBA
11/2005
1amrubicinIBA
03/2005
1Granisetron (Kytril)FDA LinkGeneric
05/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2004
1DroperidolFDA LinkGeneric
05/2004
1alpha-Linolenic Acid (Linolenic Acid)IBA
02/2004
1docosapentaenoic acidIBA
02/2004
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
02/2004
1Eicosapentaenoic AcidIBA
02/2004
1Transaminases (Aminotransferases)IBA
03/2003
1Laminin (Merosin)IBA
12/2001
1Collagen Type IV (Type IV Collagen)IBA
12/2001
1Monoclonal AntibodiesIBA
12/2001
1AntibodiesIBA
12/2001
1Indicators and Reagents (Reagents)IBA
11/2001
1trans-sodium crocetinate (crocetin)IBA
11/2001
1Dopamine (Intropin)FDA LinkGeneric
11/2001
13-Iodobenzylguanidine (Iobenguane)IBA
11/2001
1SarinIBA
11/2001
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2001
1Biomarkers (Surrogate Marker)IBA
10/2001
1IfosfamideFDA LinkGeneric
08/2001
1A 7 (A-7)IBA
01/2001
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2001
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2001
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2000
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2000
1CatecholaminesIBA
11/2000
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2000
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2000
1Immunoglobulins (Immunoglobulin)IBA
08/2000
1Amyloid (Amyloid Fibrils)IBA
08/2000

Therapy/Procedure

8Drug Therapy (Chemotherapy)
06/2010 - 01/2001
3Lymph Node Excision (Lymph Node Dissection)
08/2001 - 06/2000
2Therapeutics
06/2010 - 09/2009
2Radiotherapy
06/2010 - 01/2001
2Combination Drug Therapy (Combination Chemotherapy)
08/2001 - 03/2001
1TP protocol
02/2007
1Premedication
12/2001
1Pain Management
11/2001
1Laparoscopic Cholecystectomy
10/2001
1X-Ray Film
01/2001